AMR Control 2
Thursday 23 May 2024, 12:00-13:00 CET
Antimicrobial resistance (AMR) is a major global public health challenge. A range of actions under the One Health approach is needed to address it and keeping it on international and national political agendas is crucial.
The EU has a key role to play from legislation, to surveillance, to technical advice. Collaboration between countries is critical and requires suitable transnational governance mechanisms to foster effective links across sectors and between the European, national, regional and local levels.
But what are the key, evidence-informed interventions? What factors are critical for successful implementation? How can the EU strengthen its response to AMR? Join us to find out!
Speakers:
- Michael Anderson (University of Manchester/LSE, UK)
- Chris Fearne (World Health Assembly)
- Roser Domenech Amado (European Commission)
- Robb Butler (WHO Regional Office for Europe)
- Laurane Dubrunfaut (FPS Health, Food Chain Safety and Environment, Belgium)
Moderators:
- Dimitri Panteli and Erica Richardson (European Observatory on Health Systems and Policies)
Observatory Webinar Spotlight Series: From evidence to practice in AMR prevention and control
Antimicrobial resistance (AMR) is a major global public health challenge. With resistance to second and third-line antimicrobials growing the threat is profound. But how can we leverage our knowledge of the drivers and impacts of AMR to enable its prevention and control?
This spotlight series consists of two webinars covering different aspects of AMR control:
- The socioeconomic drivers and impacts of AMR
- Strengthening the EU response to prevention and control of AMR
As part of our ongoing work on AMR in support of Presidencies of the Council of the EU we have explored how to address the significant health and economic impacts of antimicrobial resistance (AMR) on individuals, households, health systems and society. However, in seeking sustainable solutions, the socioeconomic and sociocultural drivers of AMR are often neglected. National and international commitments to a “One-Health” approach offer some hope and bring sectors, disciplines, and communities together but despite years of policy discussion and much agreement, action on AMR is slow. What should the EU and its Member States focus on to drive change?